Abstract-Both stimulatory and suppressive responses of the sympathetic nervous system to angiotensin II (AII) Key Words: sympathetic nervous system Ⅲ angiotensin II Ⅲ calcium Ⅲ calcium channel blockers Ⅲ norepinephrine Ⅲ inositol T he renin-angiotensin and sympathetic nervous systems are homeostatically interconnected by a complex series of mutually reinforcing and mutually inhibiting interactions. In general, each of these systems tends to reinforce the pressor effects of the other as the two systems act to defend arterial pressure. Sympathetic stimulation is a major controller of juxtaglomerular cell renin release through the actions of catecholamines on juxtaglomerular cell ␤ 1 receptors. 1 The angiotensin II (AII) subsequently generated in the bloodstream can exert positive feedback on sympathetic nervous activity by several complex mechanisms, including direct stimulatory actions of AII on central and peripheral sympathetic neuronal activity and catecholamine release. [1] [2] [3] In addition to its stimulatory effects, AII can also suppress sympathetic neuronal activity in vivo. In animals and humans, complex reflex inhibition occurs when increases in arterial pressure stimulate arterial baroreflexes to cause reflex suppression of sympathetic nervous outflow. A more confusing picture emerges in whole-animal experiments designed to isolate the contributions of the peripheral sympathetic nervous system: AII infusion can facilitate, 4 suppress, 5 or have no effect 6 on norepinephrine release from postganglionic sympathetic neurons. In humans, a similar pattern of sympathetic neural responses has been reported, with some studies showing increased norepinephrine spillover 3 and others showing no response 7 or decreased norepinephrine release 3, 7, 8 in response to AII. In other excitable cell types such as cardiomyocytes or vascular smooth muscle cells, a paradoxical response has also been reported. AII treatment was shown to increase cytosolic calcium ([Ca 2ϩ ]i) by stimulation of IP 3 -dependent pathways 9,10 and was also reported to decrease [Ca 2ϩ ]i through enhanced calcium efflux. 11,12 The current studies were undertaken to examine the effects of AII on neuronal [Ca 2ϩ ]i and to investigate whether alterations in [Ca 2ϩ ]i play a role in the apparent "bidirectional" excitatory and suppressive responses to AII seen in sympathetic neurons studied in vivo. Using isolated primary sympathetic neurons from rats, we first related neuronal responses to the dose of AII and to the baseline [Ca 2ϩ ]i. To confirm that the same neuron is capable of both stimulatory and suppressive responses to AII, cells with spontaneously low [Ca 2ϩ ]i were exposed to a Ca 2ϩ ionophore and cells with spontaneously high [Ca 2ϩ ]i were exposed to nifedipine. We used losartan to investigate the role of the AT 1 receptors and confirmed IP 3 pathway dependency with an IP 3 receptor blocker and by prior
]i) in primary cultures of rat stellate ganglion neurons. Two different patterns of [Ca 2ϩ ]i responses to AII were observed: dose-dependent increases in [Ca 2ϩ ]i in cells with intrinsically low baseline [Ca 2ϩ ]i (nϭ64) and dosedependent suppression of [Ca 2ϩ ]i in neurons with intrinsically higher baseline [Ca 2ϩ ]i (nϭ46). Individual neurons could express both response patterns to AII. In neurons with low basal [Ca 2ϩ ]i, superfusion with Ca 2ϩ ionophore (ionomycin) increased [Ca 2ϩ ]i and reversed the initial AII-induced stimulatory pattern. L-type Ca 2ϩ channel antagonism (nifedipine) in neurons with high baseline [Ca 2ϩ ]i lowered [Ca 2ϩ ]i and reversed the initial AII-induced suppressive response. Both stimulatory and suppressive responses were abolished by AT 1 receptor antagonism (losartan). AII-induced stimulatory responses were blocked by IP 3 receptor antagonism (2-APB) and by thapsigargin. AII-induced suppression of neuronal [Ca 2ϩ ]i was blunted when Na-Ca exchange was impaired. We conclude that [Ca 2ϩ ]i acts as a switch for AII-mediated stimulatory and suppressive responses in individual sympathetic neurons. AT 1 receptor-mediated neuronal stimulation and suppression may allow local homeostatic adaptation to meet complex systemic needs. Key Words: sympathetic nervous system Ⅲ angiotensin II Ⅲ calcium Ⅲ calcium channel blockers Ⅲ norepinephrine Ⅲ inositol T he renin-angiotensin and sympathetic nervous systems are homeostatically interconnected by a complex series of mutually reinforcing and mutually inhibiting interactions. In general, each of these systems tends to reinforce the pressor effects of the other as the two systems act to defend arterial pressure. Sympathetic stimulation is a major controller of juxtaglomerular cell renin release through the actions of catecholamines on juxtaglomerular cell ␤ 1 receptors. 1 The angiotensin II (AII) subsequently generated in the bloodstream can exert positive feedback on sympathetic nervous activity by several complex mechanisms, including direct stimulatory actions of AII on central and peripheral sympathetic neuronal activity and catecholamine release. [1] [2] [3] In addition to its stimulatory effects, AII can also suppress sympathetic neuronal activity in vivo. In animals and humans, complex reflex inhibition occurs when increases in arterial pressure stimulate arterial baroreflexes to cause reflex suppression of sympathetic nervous outflow. A more confusing picture emerges in whole-animal experiments designed to isolate the contributions of the peripheral sympathetic nervous system: AII infusion can facilitate, 4 suppress, 5 or have no effect 6 on norepinephrine release from postganglionic sympathetic neurons. In humans, a similar pattern of sympathetic neural responses has been reported, with some studies showing increased norepinephrine spillover 3 and others showing no response 7 or decreased norepinephrine release 3, 7, 8 in response to AII. In other excitable cell types such as cardiomyocytes or vascular smooth muscle cells, a paradoxical response has also been reported. AII treatment was shown to increase cytosolic calcium ([Ca 2ϩ ]i) by stimulation of IP 3 -dependent pathways 9, 10 and was also reported to decrease [Ca 2ϩ ]i through enhanced calcium efflux. 11, 12 The current studies were undertaken to examine the effects of AII on neuronal [Ca 2ϩ ]i and to investigate whether alterations in [Ca 2ϩ ]i play a role in the apparent "bidirectional" excitatory and suppressive responses to AII seen in sympathetic neurons studied in vivo. Using isolated primary sympathetic neurons from rats, we first related neuronal responses to the dose of AII and to the baseline [Ca 2ϩ ]i. To confirm that the same neuron is capable of both stimulatory and suppressive responses to AII, cells with spontaneously low [Ca 2ϩ ]i were exposed to a Ca 2ϩ ionophore and cells with spontaneously high [Ca 2ϩ ]i were exposed to nifedipine. We used losartan to investigate the role of the AT 1 receptors and confirmed IP 3 pathway dependency with an IP 3 receptor blocker and by prior calcium depletion. The role of Na-Ca exchange was studied by using Na ϩ -free buffers.
Methods

Culture of Rat Stellate Ganglion Neurons
Details of this method have been described elsewhere. 13 Briefly, adult and newborn (2 to 4 days old) Sprague-Dawley rats were anesthetized with halothane. Thoracotomy-exposed stellate ganglia were removed, rinsed, and minced in Tyrode solution containing (in mmol/L) NaCl 124, KCl 2.6, MgCl 2 1.2, KH 2 PO 4 1.2, glucose 5, HEPES 5, NaHCO 3 3.6, and CaCl 2 1.5, pH 7.4. Minced neuronal tissues were placed in an enzyme solution containing 0.25% trypsin and 0.1% collagenase and incubated in a 36°C shaker bath for 30 minutes. The cell suspension was centrifuged at 80g for 4 minutes. The supernatant was discarded and the dissociated cells were resuspended in growth media containing MEM (Sigma), nerve growth factor-␤ 100 ng/mL (Sigma), and 10% FBS. Resuspended neurons were plated onto Thermanox TM tissue culture coverslips (Lux, Flow Laboratory Inc) precoated with laminin (20 g/mL). Cells were maintained in an incubator at 37°C under a 95% air and 8% CO 2 atmosphere. Culture media were changed twice per week. Typically, after 3 to 4 days in culture, neurons attached firmly on coverslips and developed extensive neurites. Neurons were selected for study after at least 3 days in culture. 
Fura-2 Loading of Sympathetic Neurons
Perfusion System
Experimental solution (control or drug-containing) flowed continuously through the cell chamber by gravity; the temperature of the perfusate was kept near 36°C. The volume of fluid in the cell chamber was Ϸ0.1 mL; the rate of perfusion was 0.3 to 0.4 mL/min. Perfusate containing drugs could be selected from several reservoirs with multichannel valve without interruption of flow. O 2 was continuously bubbled through the perfusion reservoirs.
Pharmacological Interventions
Once the baseline [Ca 2ϩ ]i became stabilized, AII was administered at different concentrations (1 pmol/L to 1 mol/L) to neuronal cultures.
The role of the AII receptor subtype was determined by administering AII to the neurons in the presence of the AII type I (AT 1 )-receptor blocker losartan and AII type II (AT 2 )-receptor blocker PD-123319. To assess whether the AII-induced increase in [Ca 2ϩ ]i was due to intracellular Ca 2ϩ release, neurons with a positive response to AII were rechallenged by AII in a Ca 2ϩ -free buffer and after pretreatment with thapsigargin. Furthermore, to determine whether an IP 3 -dependent mechanism was involved in intracellular Ca 2ϩ release, the effect of AII was tested in the presence of 2-aminoethoxydiphenyl borate (2-APB, 200 mol/L, Calbiochem), a specific IP 3 receptor blocker. 15 To assess the contribution of the Na-Ca exchange mechanism, AII experiments were performed under extracellular Na ϩ -free conditions. Na ϩ -free buffer was prepared by either substituting 124 mmol/L Na ϩ with equimolar N-methyl-D-glucamine (NMG) or with LiCl (Sigma-Aldrich). Finally, to determine whether altering [Ca 2ϩ ]i could change neuronal response in the same cells, neurons were exposed to the calcium ionophore ionomycin (3 mol/L) to raise baseline [Ca 2ϩ ]i or to the L-type Ca 2ϩ channel blocker nifedipine (1 mol/L) to lower baseline [Ca 2ϩ ]i. AII was then administered to these cells after a new baseline [Ca 2ϩ ]i was obtained.
Norepinephrine Release Assay
Primary sympathetic neuronal cultures were prepared as described above. Dissociated stellate ganglion cells pooled from 3 to 5 rats in each preparation were distributed to 3 to 5 collagen-coated culture dishes (Fisher Scientific) to maximize cell density. Culture medium was removed from culture dishes and replaced with a buffer solution containing NaCl 124 mmol/L, HEPES 30 mmol/L, NaHCO 
Data Analysis
The amplitude of Ca 2ϩ transients was measured with Felix software (PTI). Neuronal responses after drug treatment were expressed as mean of [Ca 2ϩ ]i (meanϮSD). The paired Student t test, ANOVA, and Tukey posttest analysis were used for statistical studies. A probability value of Ͻ0.05 was considered significant.
Results
Patterns of Neuronal Response to AII
Primary cultures of neonatal rat sympathetic neurons when exposed to brief pulses (3 minutes) of AII results in acute changes in intracellular calcium concentration ([Ca 2ϩ ]i). Based on morphology of observed Ca 2ϩ tracings, responses were grouped into two categories. In 45% (nϭ64 of 142 cells) of the neurons tested, AII exposure resulted in an increase in [Ca 2ϩ ]i (stimulatory pattern, Figure 1A ). This pattern showed an initial phase of rapid transient increase in [Ca 2ϩ ]i followed by a sustained plateau phase. In 32% (nϭ46 of 142 cells), AII caused a paradoxical decrease in [Ca 2ϩ ]i (suppressive pattern, Figure 1B ). In 22% (nϭ32 of 142 cells), AII did not elicit any response. Microscopic examination of neurons from both groups did not exhibit any morphological differences. Similar results were seen when using adult rat sympathetic neurons.
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Role of AT 1 and AT 2 Receptor Subtypes in AII-Induced Responses
To identify AII receptor subtypes involved in mediating changes in [Ca 2ϩ ]i, specific AT 1 and AT 2 receptor blockers were used. Neurons that showed stimulatory responses to 10 pmol/L AII were incubated with 10 mol/L losartan, an AT 1 receptor blocker, for 5 minutes. Losartan pretreatment completely abolished stimulatory responses when rechallenged with AII ( Figure 2A ). In neurons that initially showed suppressive responses to 10 pmol/L AII, pretreatment with 10 mol/L losartan likewise inhibited these suppressive responses when rechallenged ( Figure 2B ). Treatment with 1 mol/L PD-123319, an AT 2 receptor blocker, for 5 minutes did not modify the stimulatory nor suppressive responses to 10 pmol/L AII (data not shown). These results suggested that both stimulatory and suppressive responses caused by AII were primarily mediated by the activation of AT 1 receptors. Involvement of AT 2 receptors was not apparent. 
Role of Baseline [Ca
Involvement of Inositol Trisphosphate Pathway in AII-Induced Stimulatory Responses
To characterize the secondary signals involved in the stimulatory response, the IP 3 pathway was investigated. To directly block IP 3 receptors, neurons were incubated with 200 mol/L 2-aminoethoxydiphenyl borate (2-APB) for 5 minutes. 
Involvement of Na-Ca Exchange in AII-Induced Suppressive Responses
To explore the role of Na-Ca exchange in mediating suppression of [Ca 2ϩ ]i, AII exposures were performed under extracellular Na ϩ -free conditions. Na ϩ -free buffers were prepared by equimolar replacement (124 mmol/L) of Na suggested that the Na-Ca exchange plays a role in generation of suppressive responses.
Norepinephrine Release Profiles
To assess the role of AII in modulating norepinephrine (NE) release, we compared NE release rates between baseline and post-AII treatment. AII exposure resulted in both stimulatory and inhibitory effects on NE release (Figure 8 ). In cultures with low baseline NE release (1.7Ϯ0.2%/10 minutes), AII induced a significant increase in NE release (nϭ18). In cultures with an initially high baseline NE release (3.5Ϯ0.5%/10 minutes), AII promoted a significant inhibition of NE release (nϭ10). This bidirectional effect of AII on NE release paralleled the observation seen with AII-induced changes in cytosolic Ca 2ϩ .
Discussion
The results of this study identify complex postreceptor effects of AII on individual sympathetic neurons and identify the role of cytosolic calcium ([Ca 2ϩ ]i) as an intrinsic "calcium switch mechanism" that modulates responses to AT 1 -receptor stimulation. In cells with intrinsically low cytosolic calcium ([Ca 2ϩ ]i), which are presumably quiescent, AII activates IP 3 -mediated release of calcium from the endoplasmic reticulum, thereby activating neurons through acute increases in [Ca 2ϩ ]i. When intraneuronal [Ca 2ϩ ]i is elevated, AII causes AT 1 receptor-mediated Na-Ca exchange, which tends to reduce [Ca 2ϩ ]i, presumably passivating the activated neuron. Thus, the neuronal effects of AII (ie, stimulation or suppression) are at least partially dependent on baseline [Ca 2ϩ ]i and in turn on the cellular mechanisms that affect Ca 2ϩ influx, release, and extrusion. It would appear that each neuron can use its "Ca 2ϩ switch" to modulate its own activity level according to complex needs. After periods of neuronal quiescence, activation of the renin-angiotensin system may enhance and sustain sympathetic activation. During periods of chronic sympathetic activation, however, AII may exert a passivating effect.
The current findings are completely consistent with the well-known tachyphylaxis to infused AII that arises in humans within hours to days, a phenomenon that led to the abandonment of AII as a reliable pressor hormone in humans. 16 Our results also verify the apparent divergence in the scientific literature that includes credible descriptions of both stimulatory 1, 3, [17] [18] [19] and suppressive effects 5, 8, 20 of AII on the sympathetic nervous system. Finally, the enhancement of AII-dependent neuronal stimulation in the presence of the L-channel blocker nifedipine is consistent with the sympathoexcitation seen during long-term use of this agent in humans 21 and may help explain the potential adverse effects observed with calcium antagonists in high-risk patients. 22 The finding that both stimulatory and suppressive responses can be elicited in the same neuron argues strongly that the observed physiological effects are not mediated entirely by systemic reflexes. Furthermore, the "bidirectional" effect of AII on sympathetic neurons is clearly not due to activation of different (ie, stimulatory and inhibitory) subclasses of sympathetic neurons within sympathetic ganglia or to the stimulation of different subclasses of AII receptors, because both stimulatory and suppressive effects are blocked by the AT 1 -receptor blocker losartan (Figure 2) . Thus, the modulation of AII effects occurs at the postreceptor level and is clearly affected by the cytosolic calcium concentration ( Figure 5) .
Modulation of neuronal function by AII in vivo could occur as a result of the effects of either locally generated tissue AII or circulating AII. Plasma AII levels are Ϸ5 pmol/L in normal individuals, 3 so that the responses to picomolar dosages of AII in the current study are well within the range observed routinely in humans. Quantification of tissue concentrations of AII is considerably more difficult at present, but it has been assumed that locally generated AII modulates neuronal function as well. 23 Small changes in plasma AII would be expected to exert significant effects on the sympathetic nervous system because critical AIIdependent sympathetic modulatory effects have been attributed to the actions of AII on circumventricular control centers such as the area postrema of the medulla oblongata, which does not have a blood-brain barrier. 24 Generation of AII within the central nervous system is also well documented, and the brain synthesizes all components of the renin-angiotensin system within neurons or perineurocytes. 23 Whether the observations from this study pertain more to plasma or tissue AII cannot be determined. The current data are also consistent with histochemical findings of high concentrations of AT 1 receptors in rat sympathetic ganglion neurons, 25, 26 including stellate ganglion neurons that provide the primary sympathetic supply to the heart.
At the level of individual neurons, responses to 2-APB (an IP 3 receptor blocker) and thapsigargin (which depletes endoplasmic reticular Ca 2ϩ stores) demonstrate that AT 1 -receptormediated increases in [Ca 2ϩ ]i are due to activation of the phospholipase C-IP 3 pathway, with AII-dependent Ca 2ϩ release from the endoplasmic reticulum (ER) (Figure 6 ). Further support for the idea that AII causes increased [Ca 2ϩ ]i by releasing ER Ca 2ϩ stores comes from other confirmatory studies in our laboratory demonstrating that removal of Ca 2ϩ from the extracellular buffer only slightly reduces the acute [Ca 2ϩ ]i responses to AII (data not included). Activation of the phospholipase C-IP 3 signaling pathway is a well-known mechanism for AII-mediated cytosolic Ca 2ϩ release from the ER of many types of mammalian cells [27] [28] [29] [30] ; the current results extend these findings to include sympathetic neurons.
Suppression of neuronal [Ca 2ϩ ]i responses to AII appears to be tightly linked to altered Na-Ca exchange. This finding may serve to reconcile existing differences of opinion as to the overall effect of AII on the sympathetic nervous system. Teleologically, AII-induced sympathetic suppression may represent a conservation response that prevents exhaustion of a chronically stimulated sympathetic nervous system. Dependence of this suppressive response to AII on Na-Ca exchange is clearly demonstrated by the current experiments that altered the transmembrane sodium gradient in neurons with high baseline [Ca 2ϩ ]I, using LiCl or NMG, which reduced the Na ϩ gradient-dependent extrusion of Ca 2ϩ through Na-Ca exchange ( Figure 7 ).
An additional mechanistic link relating cytosolic Ca 2ϩ to modulation of AII-mediated neuronal activation probably occurs at the level of ER IP 3 Figure 5B ). There may also be clinical relevance to these findings. L-Type calcium channel antagonists such as nifedipine cause acute and chronic sympathetic activation, 21 a phenomenon that may be especially problematic in patients with hypertension, congestive heart failure, and myocardial infarction. 22, [33] [34] [35] Altered baroreflex inhibition could be one mechanism of sympathoinhibition in response to chronic vasodilation, but enhancement of AII-mediated neuronal activation in chronically stimulated sympathetic neurons may be another mechanism underlying chronic sympathoexcitation in high-risk patients with congestive heart failure and acute coronary syndromes. 36, 37 Whether or not these findings can be fully extrapolated to the intact nervous system remains unclear. The primary advantage of using an in vitro system is the absence of confounding physiological or reflex effects. However, this advantage is also an important drawback because the relative role of cellular and physiological modulating effects cannot be directly compared. Also, potential artifacts of culture preparation cannot be easily eliminated. Cultured sympathetic neurons go through a rigid dissection and isolation procedure that may affect cell membranes and will certainly disrupt cell-cell interactions. The use of nerve growth factor and other constituents of culture media may also influence the results. The fluorescence microscopic technique that was used measures integrated changes in [Ca 2ϩ ]i over the cell body of individual neurons. Whether these integrated changes represent similar changes in axons or dendrites is also not known. In other cell types, Ca 2ϩ is not uniformly distributed throughout the cytoplasm. Acute Ca 2ϩ transients in many somatic cells occur as dense "sparks" or waves of sparks 38 divergent neuronal responses to AII (Figures 3 and 4) . The interaction and regulation of IP 3 receptors and Na-Ca exchangers should also be examined. Initial reports have suggested that IP 3 receptors and Na-Ca exchangers colocalize in the same cellular subdomain. 40 This physical proximity may provide further evidence for the counterregulatory function of these two signaling systems. Another area of study that will be of interest is the differential expression of protein isoforms. Several IP 3 receptor and Na-Ca exchanger isoforms have been reported; an important question that can be addressed is how changes in isoform expression may affect overall regulation of cytosolic Ca 2ϩ .
Perspectives
Mutually reinforcing stimulatory responses of the sympathetic nervous and renin-angiotensin systems would tend to favor marked vasoconstriction and runaway increases in blood pressure unless a parallel system of negative interactions between the two systems also exists. The current results suggest that both positive and negative interactions between the two systems are controlled at the cellular level and are closely related to the calcium content of the cell. Teleologically, if the sympathetic nervous system (SNS) is chronically activated (neurons with high baseline calcium concentrations), additional stimulation by AII is unnecessary and may even be deleterious. On the other hand, if the SNS has been largely quiescent (cells with low baseline calcium), AII may be useful to extend or amplify the initial stress response. By integrating these whole-animal responses around the calcium metabolism of efferent SNS neurons, a "fail-safe" system may exist that integrates metabolic and neurophysiologic signals without requiring interposed central nervous system inputs or baroreflex modulation. The functional coupling between IP 3 -mediated Ca release and Ca efflux mediated by the Na-Ca exchanger is evidence of the ability of an individual neuron to integrate different stimuli. Future studies can be directed toward understanding how other cell signals (metabolic, toxic, and so forth) may influence neuronal Ca balance and whether imbalances exist in conditions such as hypertension and heart failure.
